This Senate resolution expresses support for designating May 2026 as Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month. Progressive supranuclear palsy and corticobasal degeneration are rare, rapidly progressing brain diseases that affect approximately 30,000 and 2,000 Americans respectively, causing problems with movement, balance, speech, cognition, and vision, with no current disease-modifying treatments available. The resolution highlights that these conditions are often misdiagnosed and confused with other neurological diseases like Parkinson's disease, and that patients typically become dependent on care within three to four years with a life expectancy of seven to eight years from symptom onset. The Senate supports increased research into these diseases, recognition of affected patients and their caregivers, and the goals of raising public awareness to improve diagnosis, treatment options, and quality of life for those living with these conditions.